Scarica l'app Stockscreener
2.53
0.80%
0.02
Dopo l'orario di chiusura:
2.60
0.07
+2.77%
Precedente Chiudi:
$2.51
Aprire:
$2.53
Volume 24 ore:
1.03M
Relative Volume:
0.42
Capitalizzazione di mercato:
$104.35M
Reddito:
$68.68M
Utile/perdita netta:
$-60.84M
Rapporto P/E:
-1.5813
EPS:
-1.6
Flusso di cassa netto:
$-38.42M
1 W Prestazione:
+25.87%
1M Prestazione:
+29.08%
6M Prestazione:
-19.43%
1 anno Prestazione:
-58.18%
Intervallo 1D:
$2.49
$2.66
Intervallo di 1 settimana:
$1.96
$2.66
Portata 52W:
$1.31
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Nome
Pulmonx Corp
Settore
Industria
Telefono
650-364-0400
Indirizzo
700 CHESAPEAKE DRIVE, REDWOOD CITY
Confronta LUNG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
2.53 | 103.53M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
125.46 | 214.37B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.58 | 136.01B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.09 | 134.98B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.87 | 127.88B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.08 | 48.88B | 5.88B | 1.34B | 799.60M | 2.3489 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-31 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | Iniziato | D. Boral Capital | Buy |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-04 | Iniziato | Lake Street | Buy |
| 2024-02-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | Iniziato | Craig Hallum | Buy |
| 2023-02-27 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-07-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | Iniziato | Citigroup | Buy |
| 2021-03-25 | Iniziato | Piper Sandler | Neutral |
| 2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-10-26 | Iniziato | BofA Securities | Buy |
| 2020-10-26 | Iniziato | Canaccord Genuity | Buy |
| 2020-10-26 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-26 | Iniziato | Stifel | Buy |
| 2020-10-26 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Pulmonx Corp Borsa (LUNG) Ultime notizie
Comparing Careview Communications (OTCMKTS:CRVW) and Pulmonx (NASDAQ:LUNG) - Defense World
What New Catalysts Are Shifting the Pulmonx Story for Investors - Yahoo Finance UK
Insider Selling: Daniel Florin Sells Shares of Pulmonx Corp (LUN - GuruFocus
Check out these key findings about Pulmonx Corp (LUNG) - setenews.com
Pulmonx (LUNG) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Improved Revenues Required Before Pulmonx Corporation (NASDAQ:LUNG) Stock's 26% Jump Looks Justified - simplywall.st
Insider Selling: Pulmonx (NASDAQ:LUNG) General Counsel Sells 10,278 Shares of Stock - MarketBeat
Pulmonx (NASDAQ:LUNG) CEO Glendon French III Sells 8,805 Shares - MarketBeat
Pulmonx CEO French sells $13.8k in LUNG stock - Investing.com India
Pulmonx CEO French sells $13.8k in LUNG stock By Investing.com - Investing.com Canada
Pulmonx Corp General Counsel Sells Shares to Cover Tax Obligations - TradingView
LUNG FinancialsIncome Statement - Quiver Quantitative
Pulmonx Corporation Grants 1,625,000 Equity Awards as Part of 2025 Inducement Plan - Quiver Quantitative
Pulmonx (Nasdaq: LUNG) issues 1,625,000-share inducement grants, incl. 1.6M RSUs/PSUs - Stock Titan
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of “Hold” by Brokerages - Defense World
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Check Out Pulmonx Corp (LUNG)’s Trade Data Rather Than the Analysts’ Views - Setenews
Comparing Pulmonx (NASDAQ:LUNG) and Standard BioTools (NASDAQ:LAB) - Defense World
How Pulmonx Corporation stock performs in interest rate cyclesQuarterly Performance Summary & AI Powered Market Entry Strategies - BỘ NỘI VỤ
[S-3/A] Pulmonx Corp Amended Shelf Registration Statement | LUNG SEC FilingForm S-3/A - Stock Titan
[S-8] Pulmonx Corp Employee Benefit Plan Registration | LUNG SEC FilingForm S-8 - Stock Titan
Holdings of Pulmonx Corp (LUNG) are aligned with the stars - setenews.com
Pulmonx Corporation (LUNG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Technical signs of recovery in Pulmonx CorporationQuarterly Market Summary & Daily Chart Pattern Signal Reports - newser.com
Is Pulmonx Corporation stock attractive for hedge fundsWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Will Pulmonx Corporation stock sustain high P E ratios2025 Major Catalysts & Growth Focused Entry Reports - newser.com
Pulmonx Corporation (LUNG) stock price, news, quote and history - Yahoo Finance UK
Is Pulmonx Corporation stock trading at a premium valuationAnalyst Downgrade & Fast Entry High Yield Stock Tips - newser.com
A significant driver of top-line growth: Pulmonx Corp (LUNG) - Setenews
Pulmonx (NASDAQ:LUNG) Stock Rating Upgraded by Wall Street Zen - Defense World
Is Pulmonx Corporation stock entering bullish territoryProfit Target & Stepwise Entry/Exit Trade Alerts - newser.com
Can Pulmonx Corporation stock outperform in 2025 bull marketWeekly Trade Recap & Safe Capital Preservation Plans - newser.com
Tick level data insight on Pulmonx Corporation volatility2025 Valuation Update & Precise Buy Zone Identification - newser.com
Historical volatility pattern of Pulmonx Corporation visualizedTrade Analysis Report & Long-Term Safe Return Strategies - newser.com
Pulmonx Corporation (NASDAQ:LUNG) Q3 2025 Earnings Call Transcript - Insider Monkey
Pulmonx (NASDAQ:LUNG) Receives "Buy" Rating from D. Boral Capital - MarketBeat
Pulmonx Rides Global Growth On Strong Zephyr Valve Demand - Finimize
Pulmonx stock rating reiterated at Buy by Stifel after 3Q results - Investing.com Nigeria
LUNG Stock Rating: D. Boral Capital Maintains Buy Rating with $1 - GuruFocus
How Recent Shifts Are Rewriting the Story for Pulmonx - Yahoo Finance
Pulmonx Corp (LUNG) Q3 2025 Earnings Call Highlights: Navigating Growth Challenges and ... By GuruFocus - Investing.com Canada
Pulmonx Corp (LUNG) Q3 2025 Earnings Call Highlights: Navigating Growth Challenges and Strategic Opportunities - GuruFocus
Pulmonx Corp (LUNG) Q3 2025 Earnings Call Highlights: Navigating Growth Challenges and ... - Yahoo Finance
Transcript : Pulmonx Corporation, Q3 2025 Earnings Call, Nov 12, 2025 - MarketScreener
Earnings call transcript: Pulmonx beats Q3 2025 earnings expectations By Investing.com - Investing.com Nigeria
Pulmonx Corp Azioni (LUNG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):